Sreekanth Vemulapalli MD

Adult Congenital Heart Disease, Interventional Cardiology

Cardiology, Duke University Medical Center

40 Duke Medicine CirDurham, NC 27710
Phone+1 919-684-8111

Dr. Vemulapalli is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vemulapalli's full profile Already have an account?

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 2009 - 2013
University of California (San Francisco)Residency, Internal Medicine, 2005 - 2009
Duke University School of MedicineClass of 2005

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

CA State Medical License 2007 - Present
NC State Medical License 2009 - 2027
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017

Clinical Trials

BEST vCLI Registry Start of enrollment: 2019 Dec 09
COMPLETED
Heart Watch Study: a Pragmatic Randomized Controlled Trial Start of enrollment: 2021 Aug 18
COMPLETED
NA

Publications & Presentations

PubMed

Evaluation, treatment, and outcomes in patients with possible severe aortic stenosis.
Pishoy Gouda, Derek D Cyr, Karen Chiswell, Jeremy Mercer, Paul Hofmann
American Heart Journal. 2026-10-01
Linking the TVT Registry to Medicare Advantage and Fee-for-Service Claims: Feasibility, Accuracy, and Implications for Real-World Surveillance Infrastructure.
Sean M O'Brien, Bradley G Hammill, Marie C Bradley, Charu Gandotra, David J Graham
Circulation. Cardiovascular Interventions. 2026-08-06
American Heart Association Presidential Profile: Dr Manesh Patel.
Sreekanth Vemulapalli, Adrian F Hernandez
Journal of the American Heart Association. 2026-08-04

Journal Articles

Volume-Outcome Association of Mitral Valve Surgery in the United States
Sreekanth Vemulapalli, MD, JAMA Cardiology
Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United States
Vinod H Thourani, Thomas G Gleason, Ajay J Kirtane, Sreekanth Vemulapalli, JAMA Cardiology
Focus on Transcatheter Aortic Valve Replacement Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic...
Jonathan P Piccini, Vinod H Thourani, Samir Kapadia, David Cohen, Eric Peterson, Matthew W Sherwood, Ajay Kirtane, Sreekanth Vemulapalli, Amit N Vora, Bhaskar Bhardwaj, ScienceDirect

Abstracts/Posters

[Board 017] Pre Versus Post-Procedure Clinical Event Rates and Associated Healthcare Resource Utilization in Patients Undergoing Commercial MitraClip Placement
Sreekanth Vemulapalli, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
[Board 473] Impact of Surgical Intervention on Healthcare Utilization in Patients With Non-Rheumatic Tricuspid Valve Disease
Sreekanth Vemulapalli, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019
[Board 474] Comorbidities and Outcomes in Patients With Non-Rheumatic Tricuspid Valve Disease
Sreekanth Vemulapalli, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

Insights into the PRECISE Randomized Clinical Trial
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
Engage @ACC. Studio: Vascular Innovation Shark Tank
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Is Renal Artery Intervention Dead?
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Authored Content

Volume-Outcome Association of Mitral Valve Surgery in the United StatesJuly 2020
Volume-Outcome Association of Mitral Valve Surgery in the United StatesJuly 2020
Geographic Access to Transcatheter Aortic Valve Replacement Centers in the United StatesJune 2020

Press Mentions

Costs Spike When Severe Aortic Stenosis Symptoms DevelopJuly 27th, 2026
New 10-Year TAVI Data Generally ‘Reassuring’ But Highlight ChallengesJune 16th, 2026
New Initiative Advances Early Diagnosis and Treatment of Aortic StenosisNovember 4th, 2025

Grant Support

2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)DUKE UNIVERSITY2023–2030
2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)DUKE UNIVERSITY2024–2029
2/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD)DUKE UNIVERSITY2024–2029
Machine Learning Guided Precision Genetic Testing for Identification of Monogenic Cardiovascular DisordersDUKE UNIVERSITY2024–2028
BEST-VIVA Registry (vCLI)DUKE UNIVERSITY2019–2025